First Header Logo Second Header Logo

Elizabeth Palavecino

Concepts (313)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Staphylococcal Infections
10
2020
63
3.160
Why?
Bacteremia
7
2023
58
3.050
Why?
Anti-Bacterial Agents
20
2023
309
2.990
Why?
Methicillin-Resistant Staphylococcus aureus
5
2020
29
2.380
Why?
Microbial Sensitivity Tests
16
2023
64
1.800
Why?
Staphylococcus
2
2023
6
1.700
Why?
Methicillin Resistance
5
2023
14
1.580
Why?
Staphylococcus aureus
8
2023
46
1.530
Why?
Bacteriological Techniques
9
2018
15
1.500
Why?
Pseudomonas aeruginosa
2
2020
30
1.470
Why?
Bacterial Proteins
5
2022
79
1.190
Why?
Humans
60
2023
32297
1.160
Why?
Bacteria
5
2018
50
1.100
Why?
beta-Lactamases
3
2022
8
1.090
Why?
Pneumocystis carinii
2
2020
6
1.050
Why?
Epstein-Barr Virus Infections
2
2022
10
1.000
Why?
Cross Infection
4
2019
48
0.910
Why?
Gonorrhea
2
2020
11
0.910
Why?
Klebsiella pneumoniae
2
2020
9
0.880
Why?
BK Virus
1
2022
7
0.880
Why?
Polyomavirus Infections
1
2022
22
0.860
Why?
Acinetobacter baumannii
1
2022
4
0.850
Why?
Influenza, Human
3
2019
124
0.840
Why?
Penicillin-Binding Proteins
2
2020
2
0.830
Why?
Diagnostic Errors
3
2012
46
0.830
Why?
Hematopoietic Stem Cell Transplantation
1
2022
95
0.830
Why?
Reagins
1
2022
3
0.820
Why?
Syphilis
1
2022
10
0.810
Why?
Neisseria gonorrhoeae
2
2020
7
0.770
Why?
Pseudomonas Infections
1
2020
11
0.760
Why?
Drug Contamination
2
2018
6
0.730
Why?
Azithromycin
1
2020
15
0.730
Why?
Kidney Transplantation
2
2022
518
0.720
Why?
beta-Lactam Resistance
1
2020
1
0.720
Why?
Cytomegalovirus
1
2020
28
0.710
Why?
Blood Platelets
4
2009
41
0.700
Why?
Bronchoalveolar Lavage Fluid
1
2020
77
0.700
Why?
Communicable Diseases
1
2019
21
0.690
Why?
Immunocompromised Host
5
2020
51
0.690
Why?
Syringes
1
2018
5
0.660
Why?
Antifungal Agents
5
2018
39
0.660
Why?
Anesthetics
1
2018
18
0.650
Why?
Operating Rooms
1
2018
33
0.650
Why?
Strongyloidiasis
1
2017
3
0.620
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2017
18
0.610
Why?
Drug Resistance, Bacterial
3
2020
42
0.570
Why?
Gram-Negative Bacteria
2
2013
8
0.500
Why?
Gram-Negative Bacterial Infections
2
2013
14
0.500
Why?
Molecular Diagnostic Techniques
3
2020
11
0.480
Why?
Clinical Laboratory Techniques
3
2021
25
0.460
Why?
Platelet Transfusion
4
2009
16
0.440
Why?
Shiga Toxin
1
2012
2
0.440
Why?
Shiga-Toxigenic Escherichia coli
1
2012
3
0.440
Why?
Chromatography, Affinity
1
2012
15
0.440
Why?
Feces
1
2012
36
0.440
Why?
Enterococcus faecium
1
2012
1
0.440
Why?
Enterococcus faecalis
1
2012
10
0.430
Why?
Daptomycin
1
2012
2
0.430
Why?
Escherichia coli Infections
1
2012
40
0.420
Why?
Fatal Outcome
6
2018
86
0.410
Why?
Carbapenems
2
2022
3
0.410
Why?
Mycoses
2
2011
21
0.400
Why?
Fungi
1
2011
9
0.390
Why?
Laboratories, Hospital
1
2010
3
0.370
Why?
Pathology, Molecular
1
2010
16
0.370
Why?
Bacterial Infections
3
2006
52
0.370
Why?
Mycobacterium Infections
1
2010
1
0.360
Why?
Corynebacterium Infections
1
2010
3
0.360
Why?
Mycobacterium
1
2010
3
0.360
Why?
Endocarditis, Bacterial
1
2010
10
0.360
Why?
Herpesvirus 4, Human
2
2022
9
0.350
Why?
Bone Marrow Diseases
1
2009
2
0.340
Why?
Pneumocystis Infections
1
2009
2
0.340
Why?
Lymphoma, T-Cell, Cutaneous
1
2009
4
0.340
Why?
United States
8
2020
3983
0.330
Why?
Male
16
2020
19488
0.330
Why?
Bone Marrow
1
2009
71
0.330
Why?
Amphotericin B
3
2018
12
0.320
Why?
Time Factors
6
2018
2181
0.320
Why?
Lung Diseases, Fungal
2
2018
7
0.310
Why?
Drug Resistance, Microbial
3
2022
14
0.310
Why?
Polymerase Chain Reaction
2
2021
190
0.300
Why?
Adult
13
2020
9467
0.300
Why?
Blood Transfusion
2
2004
75
0.300
Why?
Influenza A virus
2
2019
21
0.290
Why?
Drug Resistance, Fungal
2
2003
2
0.280
Why?
Fluconazole
2
2003
8
0.280
Why?
Child, Preschool
4
2020
1281
0.260
Why?
Female
18
2020
20126
0.260
Why?
Erythromycin
2
2002
7
0.260
Why?
Sepsis
2
2004
156
0.260
Why?
Sensitivity and Specificity
4
2020
600
0.260
Why?
Blood Component Transfusion
1
2004
10
0.250
Why?
Streptococcus pyogenes
2
2003
16
0.250
Why?
Seasons
2
2019
86
0.250
Why?
DNA, Viral
2
2022
52
0.250
Why?
Streptococcal Infections
2
2003
22
0.250
Why?
Laboratories
1
2023
16
0.230
Why?
Middle Aged
11
2019
11949
0.230
Why?
Length of Stay
2
2023
315
0.230
Why?
Costs and Cost Analysis
1
2023
100
0.230
Why?
Candidiasis
1
2003
4
0.230
Why?
AIDS-Related Opportunistic Infections
1
2003
9
0.230
Why?
Candida albicans
1
2003
12
0.220
Why?
Esophageal Diseases
1
2003
7
0.220
Why?
Mitosporic Fungi
1
2003
2
0.220
Why?
Cephalosporins
1
2023
8
0.220
Why?
Antibodies, Bacterial
2
2022
32
0.220
Why?
Drug Resistance, Multiple, Bacterial
1
2022
14
0.210
Why?
Viral Load
1
2022
70
0.210
Why?
Pneumonia
2
2020
67
0.210
Why?
Streptococcus pneumoniae
1
2002
39
0.210
Why?
Cell Culture Techniques
2
2014
176
0.210
Why?
Syphilis Serodiagnosis
1
2022
4
0.210
Why?
Treponema pallidum
1
2022
7
0.200
Why?
Animals
4
2020
7694
0.200
Why?
Immunoassay
1
2021
14
0.200
Why?
Bacterial Typing Techniques
2
2014
10
0.190
Why?
Carrier State
1
2020
21
0.190
Why?
Membrane Proteins
1
2002
260
0.190
Why?
Antibodies, Viral
1
2020
60
0.190
Why?
Cerebrospinal Fluid Otorrhea
1
2020
2
0.180
Why?
Cefixime
1
2020
3
0.180
Why?
HIV Seronegativity
1
2020
5
0.180
Why?
Pharynx
1
2020
13
0.180
Why?
Penicillins
1
2020
9
0.180
Why?
Osteomyelitis
1
2020
24
0.180
Why?
Tetracycline
1
2020
12
0.180
Why?
Ceftriaxone
1
2020
12
0.180
Why?
Arthritis, Infectious
1
2020
24
0.180
Why?
Virology
1
2020
1
0.180
Why?
Mycological Typing Techniques
1
2020
1
0.180
Why?
Oxacillin
1
2020
3
0.180
Why?
Bronchoalveolar Lavage
1
2020
16
0.180
Why?
Hospitals
1
2020
99
0.180
Why?
Pneumonia, Pneumocystis
1
2020
6
0.180
Why?
Cytomegalovirus Infections
1
2020
47
0.180
Why?
Enterobacteriaceae
2
2017
9
0.170
Why?
Health Facilities
1
2019
9
0.170
Why?
Clindamycin
3
2007
21
0.170
Why?
North Carolina
3
2020
1520
0.170
Why?
Drug Packaging
1
2018
5
0.170
Why?
Homosexuality, Male
1
2020
83
0.170
Why?
Blood Preservation
3
2009
9
0.160
Why?
Child
6
2016
2472
0.160
Why?
Ascomycota
1
2018
4
0.160
Why?
Strongyloides stercoralis
1
2017
3
0.150
Why?
Piperacillin
1
2017
5
0.150
Why?
Diagnosis, Differential
1
2020
525
0.150
Why?
Penicillanic Acid
1
2017
5
0.150
Why?
Antiparasitic Agents
1
2017
6
0.150
Why?
Cryptococcosis
1
2017
5
0.150
Why?
Ivermectin
1
2017
9
0.150
Why?
Pharmacists
1
2018
20
0.150
Why?
Plateletpheresis
2
2009
3
0.150
Why?
Physicians
1
2019
161
0.150
Why?
Case-Control Studies
1
2020
911
0.150
Why?
Colony Count, Microbial
3
2010
18
0.140
Why?
Culture Media
2
2009
45
0.140
Why?
Aged
5
2019
10398
0.140
Why?
Predictive Value of Tests
3
2020
877
0.140
Why?
Sphingomonas
1
2015
2
0.130
Why?
Meningitis
1
2015
9
0.130
Why?
Virulence
2
2007
22
0.130
Why?
Practice Guidelines as Topic
1
2018
410
0.130
Why?
Influenza A Virus, H1N1 Subtype
1
2016
49
0.130
Why?
Community-Acquired Infections
2
2007
32
0.130
Why?
Adolescent
5
2016
3571
0.130
Why?
Anemia, Hemolytic, Autoimmune
1
2015
4
0.130
Why?
Mucormycosis
1
2014
2
0.120
Why?
Autoantibodies
1
2015
62
0.120
Why?
Nucleic Acid Amplification Techniques
1
2014
10
0.120
Why?
Influenza B virus
1
2014
20
0.120
Why?
Young Adult
4
2016
2626
0.120
Why?
Chile
3
2006
7
0.120
Why?
Electrophoresis
1
2014
7
0.120
Why?
Multiple Organ Failure
2
2014
10
0.120
Why?
Fluorescent Antibody Technique
1
2014
94
0.120
Why?
Microscopy, Fluorescence
1
2014
88
0.120
Why?
Computational Biology
1
2014
90
0.110
Why?
United States Food and Drug Administration
2
2020
48
0.110
Why?
Diabetes Complications
1
2014
180
0.110
Why?
Hematuria
1
2012
11
0.110
Why?
Lactobacillus
1
2012
14
0.110
Why?
Urinalysis
1
2012
27
0.110
Why?
Diabetes Mellitus, Type 1
1
2014
244
0.110
Why?
Gentamicins
1
2012
6
0.100
Why?
Peritonitis
1
2012
14
0.100
Why?
Mupirocin
1
2012
3
0.100
Why?
Catheter-Related Infections
1
2012
11
0.100
Why?
Anti-Infective Agents, Local
1
2012
15
0.100
Why?
Antibiotic Prophylaxis
1
2012
38
0.100
Why?
Peritoneal Dialysis
1
2012
26
0.100
Why?
Hyphae
1
2011
1
0.100
Why?
Cerebrospinal Fluid
1
2011
13
0.100
Why?
Unnecessary Procedures
1
2011
16
0.100
Why?
Cushing Syndrome
1
2010
1
0.090
Why?
Nocardia asteroides
1
2010
2
0.090
Why?
Carcinoid Tumor
1
2010
14
0.090
Why?
Staphylococcus epidermidis
1
2010
5
0.090
Why?
Rifampin
1
2010
8
0.090
Why?
Ventriculostomy
1
2010
11
0.090
Why?
Cerebrospinal Fluid Shunts
1
2010
7
0.090
Why?
Minocycline
1
2010
11
0.090
Why?
Coated Materials, Biocompatible
1
2010
18
0.090
Why?
Urine
1
2011
68
0.090
Why?
Education, Continuing
1
2010
6
0.090
Why?
Mass Screening
1
2012
263
0.090
Why?
Organizational Innovation
1
2010
31
0.090
Why?
Calorimetry
1
2009
4
0.090
Why?
Blood
1
2009
10
0.090
Why?
Equipment Contamination
1
2009
11
0.090
Why?
Phlebotomy
1
2009
17
0.090
Why?
Geotrichosis
1
2009
1
0.090
Why?
Geotrichum
1
2009
1
0.090
Why?
Echinocandins
1
2009
5
0.090
Why?
Lipopeptides
1
2009
5
0.090
Why?
Neutropenia
1
2009
30
0.090
Why?
DNA, Bacterial
2
2007
21
0.090
Why?
Phenotype
2
2002
656
0.090
Why?
Bacterial Capsules
1
2009
5
0.090
Why?
Microscopy, Atomic Force
1
2009
6
0.090
Why?
Bacterial Adhesion
1
2009
8
0.090
Why?
Respiratory Syncytial Virus, Human
1
2008
3
0.080
Why?
Respiratory Syncytial Virus Infections
1
2008
10
0.080
Why?
Spleen
1
2009
87
0.080
Why?
Ustilaginales
1
2008
3
0.080
Why?
Fungemia
1
2008
3
0.080
Why?
Short Bowel Syndrome
1
2008
12
0.080
Why?
Antiviral Agents
1
2008
110
0.080
Why?
Skin
1
2009
217
0.080
Why?
Catheterization, Central Venous
1
2008
63
0.070
Why?
Vancomycin Resistance
1
2007
3
0.070
Why?
Molecular Epidemiology
1
2007
21
0.070
Why?
Evolution, Molecular
1
2007
34
0.070
Why?
Antibodies, Monoclonal
1
2008
250
0.070
Why?
Lung Neoplasms
1
2010
409
0.070
Why?
Disease Reservoirs
1
2006
2
0.070
Why?
Hospitals, University
1
2006
33
0.070
Why?
Bartonella henselae
1
2006
2
0.070
Why?
Serotyping
2
2003
15
0.070
Why?
Quality Control
1
2006
43
0.070
Why?
Cats
1
2006
109
0.070
Why?
Electrophoresis, Gel, Pulsed-Field
2
2003
5
0.060
Why?
Blood Donors
1
2004
13
0.060
Why?
Contact Tracing
2
2020
8
0.060
Why?
Clostridium difficile
1
2004
12
0.060
Why?
Intestinal Diseases
1
2004
16
0.060
Why?
Methicillin
1
2004
1
0.060
Why?
Clostridium Infections
1
2004
10
0.060
Why?
Sterilization
1
2003
2
0.060
Why?
Erythrocytes
1
2003
45
0.060
Why?
Pharyngeal Diseases
1
2003
9
0.060
Why?
Candidiasis, Oral
1
2003
10
0.060
Why?
Cryptococcus neoformans
1
2003
2
0.060
Why?
Candida
1
2003
7
0.060
Why?
CD4 Lymphocyte Count
1
2003
32
0.060
Why?
Risk Factors
2
2018
3876
0.050
Why?
Methyltransferases
1
2002
4
0.050
Why?
Phenazines
1
2002
1
0.050
Why?
Serologic Tests
1
2002
11
0.050
Why?
Gentian Violet
1
2002
3
0.050
Why?
False Negative Reactions
1
2002
22
0.050
Why?
Prospective Studies
3
2014
2274
0.050
Why?
Infant
2
2016
1076
0.050
Why?
Antibodies, Neutralizing
1
2020
19
0.050
Why?
Immunoglobulin G
2
2015
121
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
264
0.050
Why?
Alternaria
1
2018
1
0.040
Why?
Patient Care Management
1
2018
18
0.040
Why?
Knee
1
2018
33
0.040
Why?
Biopsy, Fine-Needle
1
2017
53
0.040
Why?
Program Evaluation
1
2018
186
0.040
Why?
Patient Care Team
1
2018
131
0.040
Why?
Attitude of Health Personnel
1
2018
182
0.030
Why?
Disease Outbreaks
2
2008
38
0.030
Why?
Aged, 80 and over
2
2014
4050
0.030
Why?
Cryoglobulins
1
2015
5
0.030
Why?
Erythrocyte Transfusion
1
2015
33
0.030
Why?
Reproducibility of Results
1
2017
779
0.030
Why?
Infant, Newborn
1
2016
681
0.030
Why?
Reagent Strips
1
2012
4
0.030
Why?
False Positive Reactions
1
2012
31
0.030
Why?
Pseudomonas
1
2012
6
0.030
Why?
Emergency Service, Hospital
1
2016
463
0.030
Why?
Survival Analysis
1
2013
491
0.020
Why?
Retrospective Studies
2
2012
3514
0.020
Why?
Nocardia Infections
1
2010
2
0.020
Why?
Adrenocorticotropic Hormone
1
2010
22
0.020
Why?
Prosthesis-Related Infections
1
2010
25
0.020
Why?
Agar
1
2009
1
0.020
Why?
Chromogenic Compounds
1
2009
1
0.020
Why?
Color
1
2009
12
0.020
Why?
Surface Properties
1
2009
32
0.020
Why?
Magnetic Resonance Imaging
1
2015
1345
0.020
Why?
Water
1
2009
57
0.020
Why?
Population Surveillance
1
2008
124
0.020
Why?
Cohort Studies
1
2012
1832
0.020
Why?
Models, Biological
1
2009
397
0.020
Why?
Blood-Borne Pathogens
1
2006
7
0.020
Why?
Seroepidemiologic Studies
1
2006
10
0.020
Why?
Fluorescent Antibody Technique, Indirect
1
2006
15
0.020
Why?
Chi-Square Distribution
1
2006
302
0.020
Why?
Evaluation Studies as Topic
1
2005
48
0.020
Why?
Treatment Outcome
1
2013
3358
0.020
Why?
Empyema, Pleural
1
2003
6
0.010
Why?
Pharyngitis
1
2003
10
0.010
Why?
Disease Transmission, Infectious
1
2003
17
0.010
Why?
Shock, Septic
1
2003
26
0.010
Why?
Pneumonia, Bacterial
1
2003
32
0.010
Why?
Family Health
1
2003
77
0.010
Why?
Drug Therapy, Combination
1
2003
301
0.010
Why?
Genotype
1
2003
742
0.010
Why?
Palavecino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (313)
Explore
_
Co-Authors (28)
Explore
_
Similar People (52)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_